AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe AUST R: 278701Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
24 Mar 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by AMGEVITA adalimumab (rch) 40mg/0.4mL injection solution syringe (ARTG ID 484554).
|